{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:29:17Z","timestamp":1791980957187,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":220,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.idcr.2024.e02057","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:25:23Z","timestamp":1723188323000},"page":"e02057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cefazolin-induced hemolytic anemia in septic arthritis: A case report"],"prefix":"10.1016","volume":"37","author":[{"given":"S. Jawad","family":"Zafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren Groft","family":"Buzzalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira A.","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2024.e02057_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia","author":"Garratty","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4\u20135","key":"10.1016\/j.idcr.2024.e02057_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy","volume":"24","author":"Garratty","year":"2010","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.idcr.2024.e02057_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: the last 30 years of changes","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology"},{"key":"10.1016\/j.idcr.2024.e02057_bib4","article-title":"Case report: drug-induced immune haemolytic anaemia caused by cefoperazone-tazobactam\/sulbactam combination therapy","volume":"8","author":"Wu","year":"2021","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.idcr.2024.e02057_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.seminhematol.2005.04.004","article-title":"The changing spectrum of drug-induced immune hemolytic anemia","volume":"42","author":"Arndt","year":"2005","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.idcr.2024.e02057_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/voxs.12469","article-title":"Drug-induced immune haemolytic anaemias","volume":"14","author":"Branch","year":"2019","journal-title":"ISBT Sci Ser"},{"issue":"2","key":"10.1016\/j.idcr.2024.e02057_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ajh.2830400209","article-title":"Cephalosporin-induced hemolysis: a case report and review of the literature","volume":"40","author":"Ehmann","year":"1992","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.idcr.2024.e02057_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1309\/JFJE-VUKN-221T-G6EV","article-title":"Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin","volume":"118","author":"Arndt","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.idcr.2024.e02057_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/BLO.0b013e31803d3aad","article-title":"Case report: cefazolin-induced hemolytic anemia","volume":"459","author":"Cerynik","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.idcr.2024.e02057_bib10","first-page":"296","article-title":"A fatal case of cefazolin-induced immune hemolytic anemia in Iran","volume":"6","author":"Moghaddam","year":"2016","journal-title":"J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.idcr.2024.e02057_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1537-2995.1978.18378205151.x","article-title":"Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity","volume":"18","author":"Moake","year":"1978","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.idcr.2024.e02057_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jamda.2008.05.001","article-title":"Hemolytic anemia from ceftriaxone in an elderly patient: a case report","volume":"9","author":"Imam","year":"2008","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.idcr.2024.e02057_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40001-021-00604-9","article-title":"Cefazolin-induced hemolytic anemia: a case report and systematic review of literature","volume":"26","author":"Mause","year":"2021","journal-title":"Eur J Med Res"},{"issue":"8","key":"10.1016\/j.idcr.2024.e02057_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/infdis\/jix384","article-title":"Human immunodeficiency virus infection increases the risk of incident autoimmune hemolytic anemia: a population-based cohort study in Taiwan","volume":"216","author":"Yen","year":"2017","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.idcr.2024.e02057_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274464","article-title":"The magnitude and associated factors of immune hemolytic anemia among human immuno deficiency virus infected adults attending University of Gondar comprehensive specialized hospital north west Ethiopia 2021 GC, cross sectional study design","volume":"17","author":"Kebede","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.idcr.2024.e02057_bib16","unstructured":"LiverTox: clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012\u2013. Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury. [Updated 2019 May 4]. Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548069\/\u3009."}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:16:07Z","timestamp":1741083367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250924001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":16,"alternative-id":["S2214250924001331"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02057","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefazolin-induced hemolytic anemia in septic arthritis: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02057"}}